Corporate Funding Request

We measure ourselves by the impact we have on people with rare tumors.
Let’s continue to innovate.

Let’s advance science together

SpringWorks supports sponsorships, medical education, and corporate memberships to advance scientific knowledge and medical care for patients with rare tumors.  

Types of Corporate Funding Requests

Sponsorship  

Funding for sponsoring third-party conferences, meetings, industry and patient advocacy events, booths and displays. Sponsorships are for specific identifiable events or activities, in exchange for a tangible benefit to SpringWorks. 

  • Individual accredited continuing education (ACE) programs cannot be supported with a sponsorship; they can only be supported with a medical education grant (described below). Note: Sponsorship of a conference or meeting at which multiple continuing education programs take place can be supported with a sponsorship.  
  • Physician group practices, physician-owned clinics, managed care organizations, pharmacy benefit managers, individuals (including HCPs), college alumni associations, and religious organizations are not eligible to request sponsorships. 

How to Apply:  

  • Organizations based in the U.S. – apply through our CyberGrants portal with this link 
  • Organizations based outside the U.S. – contact your local company representative. 

 

Medical Education:  

  • Medical education activities in the U.S.: Funding to accredited continuing education providers for the advancement of medical education for all health professionals 
  • Medical education activities outside the U.S.: Funding to independent organizations to support independent medical education programs for HCPs, with or without continuous medical education or continuous professional development accreditation, and without industry involvement or influence 
  • Ineligible Requestors both in and outside the US:  
  • Physician group practices, physician-owned clinics, managed care organizations, pharmacy benefit managers, and individuals (including HCPs) are ineligible. Organizations who are currently listed on probation by an accreditation organization or are listed on the Office of Inspector General (OIG)’s List of Excluded Individuals/Entities are also ineligible. 
  • Requirements: All medical education activities must be independent, held in an appropriate venue, open to all HCPs (e.g., not limited to a specific practice group or clinic), non-promotional, objective, and incorporate outcomes measurements. 

How to Apply:  

For medical education programs, please access our STARTone portal with this link, which opens based on your geographical location.  

  • Once you create a STARTOne account, you will be able to see any open Request for Proposals for the U.S. or Call for Grants for countries outside the U.S., as applicable. 

 

Corporate Membership: Corporate memberships in organizations inside and outside the U.S.  

  • Membership means: 
    • Belonging to a professional, advocacy or trade organization upon payment of money or non-cash benefits, and 
    • Supporting and benefitting from the organization’s portfolio of activities without expecting a specific, concrete service for the membership fee 
  • Corporate vs. Private Memberships: While a corporate membership is for our company, a private membership is for a specific employee in our company to maintain their professional standing, fulfill their duties, or support the work that they do for our company.  

How to Apply:  

  • For corporate and private memberships in organizations based in the U.S. – apply through our CyberGrants portal with this link. 
  • For corporate and private memberships in organizations based outside the U.S. – contact your local company representative. 

Areas of educational interest

Desmoid Tumors

  • Optimize multidisciplinary team decision-making, referral and management of adults with desmoid tumors (DT)
  • Improve awareness of established clinical guideline recommendations for diagnosis and management of adults with DT, including the role of surgery and systemic therapy
  • Improve understanding of adverse event management and monitoring for adults with DT treated with systemic therapies to enhance treatment adherence and persistence

Neurofibromatosis Type 1 Plexiform Neurofibromas 

  • Optimize multidisciplinary team decision-making, referral, and management for pediatric and adult patients with neurofibromatosis type 1 plexiform neurofibromas (NF1-PN)
  • Address challenges in the patient journey including transition of care for adults with NF1-PN and strategies to support personalized care across the patient’s lifespan
  • Improve awareness of clinical practice recommendations for diagnosis and management of pediatric and adult patients with NF1-PN, including the role of surgery and systemic therapy
  • Improve understanding of adverse event management and monitoring for pediatric and adult patients with NF1-PN treated with systemic therapies to enhance treatment adherence and persistence

Click here for our Guide to Corporate Funding.  

For questions about funding requests, please contact us at SW_grants@emdgroup.com.